Literature DB >> 1464275

Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases.

S L Kinsman1, E P Vining, S A Quaskey, D Mellits, J M Freeman.   

Abstract

The ketogenic diet was developed in the 1920s as a treatment for intractable childhood seizures when few antiepileptic drugs (AEDs) were available. There are still children whose seizures are refractory even to modern therapy, but use of the ketogenic diet appears to be waning. At Johns Hopkins, we continue to believe that the diet is very effective and well accepted by patients and families. To reevaluate our opinion of the efficacy and acceptability of this form of therapy in patients cared for in the 1980s with the newer AEDs, we analyzed the records of 58 consecutive patients who had been started on the diet. Before using the diet, 80% of the patients had multiple seizure types and 88% were treated with multiple AEDs; these children were among our most intractable patients. Despite this, seizure control improved in 67% of patients with the ketogenic diet, and actuarial analysis indicated that 75% of these improved patients continued the diet for at least 18 months. Sixty-four percent had AEDs reduced, 36% became more alert, and 23% had improved behavior. The improvement in these patients with intractable seizures and the length of time that families maintained the regimen indicate that the ketogenic diet continues to have a very useful therapeutic role in selected patients and their families.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464275     DOI: 10.1111/j.1528-1157.1992.tb01770.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  31 in total

Review 1.  Pharmacokinetic considerations in the treatment of childhood epilepsy.

Authors:  Jamie T Gilman; Michael Duchowny; Ana E Campo
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

2.  Food for thought: the ketogenic diet and adverse effects in children.

Authors:  Michael S Duchowny
Journal:  Epilepsy Curr       Date:  2005 Jul-Aug       Impact factor: 7.500

3.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

4.  Achieving and maintaining compliance with the ketogenic diet.

Authors:  A Amari; N C Grace; W W Fisher
Journal:  J Appl Behav Anal       Date:  1995

5.  Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study.

Authors:  Moran Artzi; Gilad Liberman; Nachum Vaisman; Felix Bokstein; Faina Vitinshtein; Orna Aizenstein; Dafna Ben Bashat
Journal:  J Neurooncol       Date:  2017-01-10       Impact factor: 4.130

6.  A ketogenic diet reduces long-term potentiation in the dentate gyrus of freely behaving rats.

Authors:  Jessica L Koranda; David N Ruskin; Susan A Masino; J Harry Blaise
Journal:  J Neurophysiol       Date:  2011-05-25       Impact factor: 2.714

7.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease.

Authors:  Y Kashiwaya; T Takeshima; N Mori; K Nakashima; K Clarke; R L Veech
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

8.  Identification of cerebral acetone by 1H-MRS in patients with epilepsy controlled by ketogenic diet.

Authors:  K J Seymour; S Bluml; J Sutherling; W Sutherling; B D Ross
Journal:  MAGMA       Date:  1999-03       Impact factor: 2.310

Review 9.  Ketone esters increase brown fat in mice and overcome insulin resistance in other tissues in the rat.

Authors:  Richard L Veech
Journal:  Ann N Y Acad Sci       Date:  2013-08-02       Impact factor: 5.691

10.  Treatment of Lennox-Gastaut syndrome: overview and recent findings.

Authors:  Kenou van Rijckevorsel
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.